Page 378 - Read Online

Marasco et al. Hepatoma Res 2020;6:33 I http://dx.doi.org/10.20517/2394-5079.2020.01 Page 13 of 19

18. Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, et al. Optimal duration of the early and late recurrence of hepatocellular
carcinoma after hepatectomy. World J Gastroenterol 2015;21:1207-15.
19. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, et al. A system of classifying microvascular invasion to predict outcome after
resection in patients with hepatocellular carcinoma. Gastroenterology 2009;137:850-5.
20. Pawlik TM, Esnaola NF, Vauthey JN. Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic
variations. Liver Transpl 2004;10:S74-80.
21. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts clinical decompensation
in patients with compensated cirrhosis. Gastroenterology 2007;133:481-8.
22. Colecchia A, Colli A, Casazza G, Mandolesi D, Schiumerini R, et al. Spleen stiffness measurement can predict clinical complications in
compensated HCV-related cirrhosis: a prospective study. J Hepatol 2014;60:1158-64.
23. Colecchia A, Marasco G, Taddia M, Montrone L, Eusebi LH, et al. Liver and spleen stiffness and other noninvasive methods to assess
portal hypertension in cirrhotic patients: a review of the literature. Eur J Gastroenterol Hepatol 2015;27:992-1001.
24. Colecchia A, Ravaioli F, Marasco G, Festi D. Spleen stiffness by ultrasound elastography. In: Berzigotti A, Bosch J, editors. Diagnostic
methods for cirrhosis and portal hypertension. Cham, Springer International Publishing; 2018. pp. 113-37.
25. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, et al. Hepatic venous pressure gradient predicts development of hepatocellular
carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923-8.
26. Jung KS, Kim SU, Choi GH, Park JY, Park YN, et al. Prediction of recurrence after curative resection of hepatocellular carcinoma using
liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012;19:4278-86.
27. Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, et al. Analysis of the risk factors for early death due to disease recurrence or
progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol 2012;10:107.
28. Liu L, Miao R, Yang H, Lu X, Zhao Y, et al. Prognostic factors after liver resection for hepatocellular carcinoma: a single-center
experience from China. Am J Surg 2012;203:741-50.
29. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IOL, et al. Tumor size predicts vascular invasion and histologic grade:
Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplant 2005;11:1086-92.
30. Colecchia A, Scaioli E, Montrone L, Vestito A, Di Biase AR, et al. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular
carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. J Hepatol 2011;54:300-5.
31. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, et al. Preoperative assessment of hepatocellular carcinoma tumor grade
using needle biopsy. Ann Surg 2007;245:435-42.
32. Jung SM, Kim JM, Choi GS, Kwon CHD, Yi NJ, et al. Characteristics of early recurrence after curative liver resection for solitary
hepatocellular carcinoma. J Gastrointest Surg 2019;23:304-11.
33. Lau WY, Sangro B, Chen PJ, Cheng SQ, Chow P, et al. Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the
emerging role for radioembolization using yttrium-90. Oncology 2013;84:311-8.
34. Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular
carcinoma: a phase 2 study. Hepatology 2013;57:1826-37.
35. Hirokawa F, Hayashi M, Miyamoto Y, Asakuma M, Shimizu T, et al. Outcomes and predictors of microvascular invasion of solitary
hepatocellular carcinoma. Hepatol Res 2014;44:846-53.
36. Kaibori M, Ishizaki M, Matsui K, Kwon AH. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma. J
Surg Oncol 2010;102:462-8.
37. Rodríguez-Perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, et al. A systematic review of microvascular invasion in
hepatocellular carcinoma: Diagnostic and prognostic variability. Ann Surg Oncol 2013;20:325-39.
38. Kim JM, Joh JW, Yi NJ, Choi GS, Kim K, et al. Predicting hepatocellular carcinoma recurrence beyond milan criteria after liver resection
for solitary hepatocellular carcinoma. J Gastrointest Surg 2019; Epub ahead of print. doi: 10.1007/s11605-019-04363-1.
39. Zhao H, Hua Y, Lu Z, Gu S, Zhu L, et al. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular
carcinoma ≤ 5 cm without macrovascular invasion. Oncotarget 2017;8:61203-14.
40. Cucchetti A, Cescon M, Ercolani G, Bigonzi E, Torzilli G, et al. A comprehensive meta-regression analysis on outcome of anatomic
resection versus nonanatomic resection for hepatocellular carcinoma. Ann Surg Oncol 2012;19:3697-705.
41. Shi M, Guo RP, Lin XJ, Zhang YQ, Chen MS, et al. Partial hepatectomy with wide versus narrow resection margin for solitary
hepatocellular carcinoma. Ann Surg 2007;245:36-43.
42. Lai ECS, You KT, Ng IOL, Shek TWH. The pathological basis of resection margin for hepatocellular carcinoma. World J Surg
1993;17:786-90.
43. Tsilimigras DI, Sahara K, Moris D, Hyer JM, Paredes AZ, et al. Effect of surgical margin width on patterns of recurrence among patients
undergoing R0 hepatectomy for T1 hepatocellular carcinoma: an international multi-institutional analysis. J Gastrointest Surg 2019; Epub
ahead of print. doi: 10.1007/s11605-019-04275-0.
44. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating
cirrhosis. Ann Surg 1991;214:114-7.
45. Guo Y, Chua DW, Koh YX, Lee SY, Cheow PC, et al. Preoperative predictors including the role of inflammatory indices in predicting
early recurrence after re-resection for recurrent hepatocellular carcinoma. World J Surg 2019;43:2587-94.
46. Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and
prognosis. Ann Surg 2015;261:947-55.
47. Zhang X, Bai Y, Xu L, Zhang B, Feng S, et al. Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma